Back to results
US 5,288,612 AGranted
Assay methods for detecting serum proteases, particularly activated protein C
AssigneeThe Scripps Research Institute
InventorsJohn H. Griffin, Andras Gruber
Life of this patent
Estimating the term…
Abstract
The invention describes diagnostic methods and compositions for determining the amount of protease in a body fluid sample. In particular, the invention detects proteases by a method in which both a reversible inhibitor of the protease and an irreversible inhibitor of interfering proteases during the detection step are employed to increase the sensitivity of the enzyme capture assay. The assay detects normal serum levels of activated protein C.
Claims9
A method for determining the amount of a protease in a body fluid sample comprising the steps of:
- a) contacting an immobilized antibody molecule composition, comprising antibody molecules affixed to a solid support, with an irreversible protease inhibitor in an amount of inhibitor sufficient to inhibit any protease associated with the composition to form a first admixture, said antibody molecules immunoreactive with said protease to form an immunoreaction complex having protease activity and the ability to bind a reversible protease inhibitor;
- b) maintaining the first admixture for a time period sufficient for said irreversible protease inhibitor to inhibit said protease and form a protease activity-free immobilized antibody composition;
- c) removing excess irreversible protease inhibitor from said protease activity-free immobilized antibody composition formed in step (b);
- d) admixing a body fluid sample with a coagulation inhibiting buffer containing a protease inhibiting amount of said reversible protease inhibitor, to form a second admixture;
- e) admixing said second admixture with the protease activity-free antibody composition formed in step (c) to form an immunoreaction admixture having a liquid phase and a solid phase;
- f) maintaining said immunoreaction admixture under immunoreaction conditions for a time period sufficient for said protease present in said body sample to immunoreact with the antibody molecules present on the solid support and form a first solid-phase immunoreaction product;
- g) removing the reversible protease inhibitor from said first solid phase immunoreaction product to form an inhibitor-free solid-phase immunoreaction product;
- and
- h) determining the amount of said protease present in the inhibitor-free solid-phase immunoreaction product formed in step (g) and thereby the amount of protease in the body sample.
6 more elements
Dependencies are inferred from the claim text.